Liver injury in patients hospitalized for COVID-19: possible role of therapy
M Gabrielli, L Franza, A Esperide, I Gasparrini… - Vaccines, 2022 - mdpi.com
Patients with COVID-19 show a high prevalence of liver injury. The pattern of this liver
damage is still not fully understood. Different etiopathogenetic factors may concur; from a …
damage is still not fully understood. Different etiopathogenetic factors may concur; from a …
Clinical significance and diagnostic utility of NLR, LMR, PLR and SII in the course of COVID-19: a literature review
JW Kosidło, B Wolszczak-Biedrzycka… - Journal of …, 2023 - Taylor & Francis
Nowadays, society is increasingly struggling with infectious diseases that are characterized
by severe course and even death. Recently, the whole world has faced the greatest …
by severe course and even death. Recently, the whole world has faced the greatest …
[HTML][HTML] The journey of antimalarial drugs against SARS-CoV-2
AA Sarhan, NA Ashour, AA Al‐Karmalawy - Informatics in medicine …, 2021 - Elsevier
The recent outbreak of coronavirus pandemic (COVID-19) introduced by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has greatly affected the global public …
respiratory syndrome coronavirus 2 (SARS-CoV-2) has greatly affected the global public …
Challenges in the differential diagnosis of COVID-19 pneumonia: a pictorial review
COVID-19 pneumonia represents a maximum medical challenge due to the virus's high
contagiousness, morbidity, and mortality and the still limited possibilities of the health …
contagiousness, morbidity, and mortality and the still limited possibilities of the health …
Soluble urokinase receptor as a promising marker for early prediction of outcome in COVID-19 hospitalized patients
F Napolitano, G Di Spigna, M Vargas… - Journal of Clinical …, 2021 - mdpi.com
The Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, has rapidly spread to
become a global pandemic, putting a strain on health care systems. SARS-CoV-2 infection …
become a global pandemic, putting a strain on health care systems. SARS-CoV-2 infection …
[HTML][HTML] Can Panax ginseng help control cytokine storm in COVID-19?
JH Choi, YH Lee, TW Kwon, SG Ko, SY Nah… - Journal of Ginseng …, 2022 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) is currently a pandemic caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 are directly associated …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 are directly associated …
[HTML][HTML] Impact of COVID-19 lockdown on anthropometric variables, blood pressure, and glucose and lipid profile in healthy adults: a before and after pandemic …
JIR Manent, BA Jané, PS Cortés, C Busquets-Cortés… - Nutrients, 2022 - ncbi.nlm.nih.gov
In December 2019, 27 cases of pneumonia were reported in Wuhan. In 2020, the causative
agent was identified as a virus called SARS-CoV-2. The disease was called “coronavirus …
agent was identified as a virus called SARS-CoV-2. The disease was called “coronavirus …
Dysprosium tungstate incorporated on exfoliated layered molybdenum disulfide-based a flexible and wearable piezoelectric nanogenerator for the dual purpose of …
The rapid spread of the novel coronavirus (COVID-19), including the Omicron, and Delta
variants, has resulted in severe economic losses and health issues worldwide. This crisis …
variants, has resulted in severe economic losses and health issues worldwide. This crisis …
[HTML][HTML] The association of posterior reversible encephalopathy syndrome with COVID-19: a systematic review
S Iftikhar, AU Rehman, MZ Ameer, A Nawaz… - Annals of Medicine and …, 2021 - Elsevier
The rise in Coronavirus disease 2019 (COVID-19) cases is revealing its unique neurological
manifestations. In light of the emerging evidence, a possible association with Posterior …
manifestations. In light of the emerging evidence, a possible association with Posterior …
Efficacy and outcome of remdesivir and tocilizumab combination against dexamethasone for the treatment of severe COVID-19: A randomized controlled trial
ATM Mohiuddin Chowdhury, A Kamal… - Frontiers in …, 2022 - frontiersin.org
Objective: In this study, we investigated the efficacy and safety of remdesivir and tocilizumab
combination therapy against dexamethasone for the management of severe COVID-19 …
combination therapy against dexamethasone for the management of severe COVID-19 …